Procter & Gamble Health Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Procter & Gamble Health wird ein Gewinn- und Umsatzwachstum von 11.3% bzw. 8.8% pro Jahr prognostiziert, während der Gewinn pro Aktie um 11.3% pro Jahr wachsen soll.
Wichtige Informationen
11.3%
Wachstumsrate der Gewinne
11.3%
EPS-Wachstumsrate
| Pharmaceuticals Gewinnwachstum | 17.9% |
| Wachstumsrate der Einnahmen | 8.8% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 06 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Recent updates
Procter & Gamble Health (NSE:PGHL) Is Due To Pay A Dividend Of ₹60.00
Nov 15
Risks To Shareholder Returns Are Elevated At These Prices For Procter & Gamble Health Limited (NSE:PGHL)
Nov 05Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Sep 28Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Aug 27Earnings Not Telling The Story For Procter & Gamble Health Limited (NSE:PGHL)
Jun 08Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)
Feb 14Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00
Sep 29Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 10Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)
Mar 30We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right
Nov 17Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50
Oct 23Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50
Oct 09Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit
Feb 16Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?
Oct 04Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock
May 10Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?
Mar 23Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 02Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?
Jan 31Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like
Jan 10
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?
Dec 19Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 01Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 6/30/2026 | 13,536 | 2,650 | N/A | N/A | 1 |
| 6/30/2025 | 12,546 | 2,376 | N/A | N/A | 1 |
| 9/30/2024 | 11,597 | 2,177 | N/A | N/A | N/A |
| 6/30/2024 | 11,513 | 2,010 | 2,066 | 2,283 | N/A |
| 3/31/2024 | 11,686 | 2,140 | N/A | N/A | N/A |
| 12/31/2023 | 12,370 | 2,267 | 1,527 | 1,740 | N/A |
| 9/30/2023 | 12,370 | 2,314 | N/A | N/A | N/A |
| 6/30/2023 | 12,296 | 2,295 | 1,935 | 2,360 | N/A |
| 3/31/2023 | 12,243 | 2,408 | N/A | N/A | N/A |
| 12/31/2022 | 11,712 | 2,328 | 2,718 | 3,349 | N/A |
| 9/30/2022 | 11,392 | 2,008 | N/A | N/A | N/A |
| 6/30/2022 | 11,144 | 1,925 | 1,316 | 1,695 | N/A |
| 3/31/2022 | 11,039 | 1,853 | N/A | N/A | N/A |
| 12/31/2021 | 10,552 | 1,499 | 816 | 1,157 | N/A |
| 9/30/2021 | 10,176 | 1,729 | N/A | N/A | N/A |
| 6/30/2021 | 10,087 | 1,768 | 1,947 | 2,473 | N/A |
| 3/31/2021 | 9,219 | 1,884 | N/A | N/A | N/A |
| 12/31/2020 | 9,308 | 2,191 | N/A | N/A | N/A |
| 9/30/2020 | 9,274 | 1,894 | N/A | N/A | N/A |
| 6/30/2020 | 8,886 | 1,659 | 1,414 | 1,569 | N/A |
| 3/31/2020 | 9,237 | 1,645 | N/A | N/A | N/A |
| 12/31/2019 | 9,266 | 1,588 | 1,512 | 1,619 | N/A |
| 9/30/2019 | 8,942 | 1,340 | N/A | N/A | N/A |
| 6/30/2019 | 8,952 | 1,394 | N/A | N/A | N/A |
| 3/31/2019 | 8,819 | 1,281 | N/A | N/A | N/A |
| 12/31/2018 | 8,490 | 1,017 | -1,571 | -1,304 | N/A |
| 9/30/2018 | 12,290 | 1,349 | N/A | N/A | N/A |
| 6/30/2018 | 12,087 | 1,140 | N/A | N/A | N/A |
| 3/31/2018 | 11,762 | 1,018 | N/A | N/A | N/A |
| 12/31/2017 | 6,981 | 610 | N/A | 537 | N/A |
| 9/30/2017 | 10,523 | 828 | N/A | N/A | N/A |
| 6/30/2017 | 10,088 | 797 | N/A | N/A | N/A |
| 3/31/2017 | 10,177 | 823 | N/A | N/A | N/A |
| 12/31/2016 | 9,926 | 791 | N/A | 1,070 | N/A |
| 9/30/2016 | 9,810 | 723 | N/A | N/A | N/A |
| 6/30/2016 | 9,681 | 572 | N/A | N/A | N/A |
| 3/31/2016 | 9,589 | 562 | N/A | N/A | N/A |
| 12/31/2015 | 9,383 | 536 | N/A | 835 | N/A |
| 9/30/2015 | 9,148 | 401 | N/A | N/A | N/A |
| 6/30/2015 | 8,798 | 451 | N/A | N/A | N/A |
| 3/31/2015 | 8,712 | 493 | N/A | N/A | N/A |
| 12/31/2014 | 8,662 | 432 | N/A | 50 | N/A |
| 9/30/2014 | 8,544 | 516 | N/A | N/A | N/A |
| 6/30/2014 | 8,409 | 498 | N/A | N/A | N/A |
| 3/31/2014 | 8,082 | 455 | N/A | N/A | N/A |
| 12/31/2013 | 7,965 | 559 | N/A | 5 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: PGHLDas prognostizierte Gewinnwachstum (11.3% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: PGHLDie Erträge des Unternehmens (11.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Indian (17.9% pro Jahr).
Hohe Wachstumserträge: PGHLDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: PGHLDie Einnahmen des Unternehmens (8.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Indian (10.5% pro Jahr).
Hohe Wachstumseinnahmen: PGHLDie Einnahmen des Unternehmens (8.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von PGHL in 3 Jahren voraussichtlich hoch sein wird